Resultados de la búsqueda 241-250 of 12860 for Folate deficiency

  1. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  2. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  3. Enfermedades infecciosas - Ensayos clínicos - Mayo Clinic

    Immunity to Hepatitis B through vaccination in patients with inflammatory bowel disease and chronic liver disease is crucial due to high risk of morbidity. Part ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma ...

  5. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial compares the effect of high dose chemotherapy and the patients' own (autologous) stem cells to observation only in patients with ...

  6. Obstetricia y Ginecología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to investigate if complete pelvic peritonectomy is associated with improved quality of life in patients with chronic pelvic pain ...

  7. Hematología - Ensayos clínicos - Mayo Clinic

    Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumor recurrences. Fertility Outcomes in Lymphoma Patients.

  9. Laser interstitial thermal therapy (LITT) - Mayo Clinic

    This minimally invasive technique uses heat to target and destroy brain tissue. Find out when it may be used, potential benefits, and key limitations.

  10. Hematología - Ensayos clínicos - Mayo Clinic

    Romidepsin and lenalidomide may stop the growth of cancer cells by blocking enzymes needed for cell growth. Giving rituximab together with romidepsin and ...